BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Usman S, Jamal A, Teh MT, Waseem A. Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance. Front Oral Health 2020;1:603160. [PMID: 35047986 DOI: 10.3389/froh.2020.603160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Balachander K, Paramasivam A. Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer. Oral Oncology 2022;127:105825. [DOI: 10.1016/j.oraloncology.2022.105825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Balachander K, Roy A, Priyadharsini JV, Murugan S, Paramasivam A. Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer. Oral Oncology 2022;128:105857. [DOI: 10.1016/j.oraloncology.2022.105857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Patra S, Patil S, Das S, Bhutia SK. Epigenetic dysregulation in autophagy signaling as a driver of viral manifested oral carcinogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022. [DOI: 10.1016/j.bbadis.2022.166517] [Reference Citation Analysis]
4 Sekaran S, Pitchaiah S, Ganapathy D. Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer? Oral Oncol 2022;131:105973. [PMID: 35738155 DOI: 10.1016/j.oraloncology.2022.105973] [Reference Citation Analysis]